Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor α is frequent in resectable non-small cell lung cancer but does not predict tumor progression

Clinical Cancer Research

Volumn 3, Issue 4, 1997, Pages 515-522

  Rusch, Valerie ^a   Klimstra, David ^a   Venkatraman, Ennapadam ^a   Pisters, Peter W T ^a,b   Langenfeld, John ^a   Dmitrovsky, Ethan ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SURVIVAL; TUMOR GROWTH;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LUNG NEOPLASMS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SURVIVAL RATE; TIME FACTORS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0030980781     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Brennan, J. A., Boyle, J. O., Koch, W. M., Goodman, S. N., Hruban, R. H., Eby, Y. J., Couch, M. J., Forastiere, A. A., and Sidransky, D. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 332: 712-717, 1995.
2. Stegelmeier, B. L., Gillett, N. A., Hahn, F. F., Rebar, A. H., and Kelly, G. Expression of transforming growth factor alpha and epidermal growth factor receptor in rat lung neoplasms induced by plutonium-239. Radiat. Res., 140: 191-198, 1994.
3. Cuttita, F., Camey, D. N., and Mulshine, J. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer. Nature (Lond), 316: 823-826, 1985.
4. Reynolds, F. H., Jr., Todaro, G. J., Fryling, C., and Stephenson, J. R. Human transforming growth factors induce tyrosine phosphorylation of EGF receptors. Nature (Lond.), 292: 259-262, 1981.
5. Rusch, V., Klimstra, D., Linkov, I., and Dmitrovsky, E. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia, and coexpression precedes squamous cell carcinoma development. Cancer Res., 55: 1365-1372, 1995.
6. Rusch, V., Baselga, J., Cordon-Cardo, C., Orazem, J., Zaman, M., Hoda, S., McIntosh, J., Kurie, J., and Dmitrovsky, E. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res., 53: 2379-2385, 1993.
7. Veale, D., Kerr, N., Gibson, G. J., Kelly, P. J., and Harris, A. L. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br. J. Cancer, 68: 162-165, 1993.
8. Veale, D., Ashcroft, T., Marsh, C., Gibson, G. J., and Harris, A. L. Epidermal growth factor receptors in non-small cell lung cancer. Br. J. Cancer, 55: 513-516, 1987.
9. Tateishi, M., Ishida, T., Mitsudomi, T., Kaneko, S., and Sugimachi, K. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res., 50: 7077-7080, 1990.
10. Martini, N., and Flehinger, B. J. The role of surgery in N2 lung cancer. Surg. Clin. North Am., 67: 1037-1049, 1987.
11. Tisi, G. M., Friedman, P. J., Peters, R. M., Pearson, F. G., Carr, D., Lee, R. E., and Selawry, O. Clinical staging of primary lung cancer. Am. Rev. Respir. Dis., 127: 659-664, 1983.
12. Mountain, C. F. A new international staging system for lung cancer. Chest, 89(Suppl.): 225S-233S, 1986.
13. Miller, W. H., Moy, D., Li, A., Grippo, J. F., and Dmitrovsky, E. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line. Oncogene, 5: 511-517, 1990.
14. Gunning, P., Ponte, P., Okayama, H., Engel, J., Balu, H., and Kedes, L. Isolation and characterization of full-length cDNA clones for human, α, β, and τ-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol. Cell. Biol., 3: 787-795, 1983.
15. Southern, E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol., 98: 503-517, 1975.
16. Kaplan, E. L., and Meier, P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
17. Peto, R., and Peto, J. Asymptotically efficient rank invariant test procedures. J. R. Statist. Soc., 135: 185-206, 1972.
18. Viallet, J., and Minna, J. D. Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer. Am. J. Respir. Cell Mol. Biol., 2: 225-232, 1990.
19. Soderdahl, G., Betscholtz, C., Johansson, A., Nilsson, K., and Bergh, J. Differential expression of platelet-derived growth factor and transforming growth factor genes in small- and non-small cell human lung carcinoma lines. Int. J. Cancer, 41: 636-641, 1988.
20. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
21. Plowman, G. D., Green, J. M., McDonald, V. L., Neubauer, M. G., Disteche, C. M., Todaro, G. J., and Shoyab, M. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumorinhibitory activity. Mol. Cell. Biol., 10: 1969-1981, 1990.
22. Haeder, M., Rotsch, M., Bepler, G., Hennig, C., Havemann, K., Heimann, B., and Moelling, K. Epidermal growth factor receptor expression in human lung cancer cell lines. Cancer Res., 48: 1132-1136, 1988.
23. Cerny, T., Barnes, D. M., Hasleton, P., Barber, P. V., Healy, K., Gullick, W., and Thatcher, N. Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br. J. Cancer, 54: 265-269, 1986.
24. Cline, M. J., and Battifora, H. Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristics. Cancer (Phila.), 60: 2669-2674, 1987.
25. Dazzi, H., Hasleton, P. S., Thatcher, N., Barnes, D. M., Wilkes, S., Swindell, R., and Lawson, R. A. M. Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival. Br. J. Cancer, 59: 746-749, 1989.
26. Hendler, F. J., and Ozanne, B. W. Human squamous cell lung cancers express increased epidermal growth factor receptors. J. Clin. Invest., 74: 647-651, 1984.
27. Sobol, R. E., Astarita, R. W., Hofeditz, C., Masui, H., Fairshter, R., Royston, I., and Mendelsohn, J. Epidermal growth factor receptor expression in human lung carcinomas defined by a monoclonal antibody. J. Natl. Cancer Inst., 79: 403-407, 1987.
28. Hwang, D. L., Tay, Y-C., Lin, S. S., and Lev-Ran, A. Expression of epidermal growth factor receptors in human lung tumors. Cancer (Phila.). 55: 2260-2263, 1986.
29. Veale, D., Kerr, N., Gibson, G. J., and Harris, A. L. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res., 49: 1313-1317, 1989.
30. Dittadi, R., Gion, M., Pagan, V., Brazzale, A., Del Maschio, O., Bargossi, A., Busetto, A., and Bruscagnin, G. Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue. Br. J. Cancer, 64: 741-744, 1991.
31. Lee, J. S., Ro, J. S., Eisbruch, A., Shtalrid, M., Ferrell, R. E., Gutterman, J. U., and Blick, M. Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor gene. Cancer Res., 48: 4045-4048, 1988.
32. Berger, M. S., Gullick, W. J., Greenfield, C., Evans, S., Addis, B. J., and Waterfield, M. D. Epidermal growth factor receptors in lung tumours. J. Pathol., 152: 297-307, 1987.
33. Kaseda, S., Ueda, M., Ozawa, S., Ishihara, T., Abe, O., and Shimizu, N. Expression of epidermal growth factor receptors in four histologic cell types of lung cancer. J. Surg. Oncol., 42: 16-20, 1989.
34. Lee, J. S., Blick, M., Milici, A., and Gutterman, J. Enhanced expression of the epidermal growth factor receptor gene without gene amplification or rearrangement in uncultured non-small cell lung cancer. Proc. Am. Assoc. Cancer Res., 28: 20, 1987.
35. Lee, J. S., Ro, J. Y., Sahin, A., and Hittelman, W. Expression of epidermal growth factor receptor (EGFR): a favorable prognostic factor for surgically resected non-small cell lung cancer. Proc. Am. Soc. Clin. Oncol., 8: A878, 1989.
36. Tateishi, M., Ishida, T., Kohclono, S., and Hamatake, M. Prognostic influence of the co-expression of epidermal growth factor receptor and c-erB-2 protein in human lung adenocarcinoma. Surg. Oncol., 3: 109-113, 1994.
37. Giatromanolaki, A., Gorgoulis, V., Chetty, R., and Koukourakis, M. I. C-erB-2 oncoprotein expression in operable non-small cell lung cancer. Anticancer Res., 16: 987-993, 1996.
38. Pfieffer, P., Clausen, P. P., Andersen, K., and Rose, C. Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated nonsmall cell lung cancer: an immunohistochemical study on cryosections. Br. J. Cancer, 74: 86-91, 1996.
39. Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchi, H., Angeletti, C. A., Pingitore, R., Pepe, S., Basolo, F., and Bevilacqua, G. Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur. J. Cancer, 31A: 178-183, 1995.
40. Kirk, J., Carmichael, J., Stratford, I. J., and Harris, A. L. Selective toxicity of TGF-α-PE40 to EGFR-positive cell lines: selective protection of low EGFR-expressing cell lines by EGF. Br. J. Cancer, 69: 988-994, 1994.
41. Dean, C., Modjtahedi, H., Eccles, S., Box, G., and Styles, J. Immunotherapy with antibodies to the EGF receptor. Int. J. Cancer, 8: 103-107, 1994.
42. Hirota, N., Ueda, M., Ozawa, S., Abe, O., and Shimizu, N. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody. Cancer Res., 49: 7106-7109, 1989.
43. Divgi, C. R., Welt, S., Kris, M., Real, F. X., Yeh, S. D. J., Gralla, R., Merchant, B., Schweighart, S., Unger, M., Larson, S. M., and Mendelsohn, J. Phase I and imaging trial of indium 111-labeled antiepidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. J. Natl. Cancer Inst., 83: 97-104, 1991.
44. Baselga, J., Norton, L., Masui, H., Pandiella, A., Coplan, K., Miller, W. H., Jr., and Mendelsohn, J. Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J. Natl. Cancer Inst., 85: 1327-1333, 1993.
45. Fry, D. W., and Bridges, A. J. Inhibitors of protein tyrosine kinases. Curr. Opin. Biotechnol., 6: 662-667, 1995.